Phibro Animal Health Corporation
PAHC
$47.92
-$1.67-3.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 376.73% | 289.61% | 1,897.68% | 141.54% | 30.53% |
| Total Depreciation and Amortization | 31.40% | 37.66% | 27.18% | 20.13% | 12.43% |
| Total Amortization of Deferred Charges | 31.20% | 40.96% | 38.77% | 28.23% | 18.98% |
| Total Other Non-Cash Items | 1,189.60% | 608.40% | -60.92% | -120.69% | -61.60% |
| Change in Net Operating Assets | -1,161.29% | -278.40% | -165.11% | -28.80% | -124.12% |
| Cash from Operations | 67.61% | -8.59% | -8.53% | 9.92% | -25.21% |
| Capital Expenditure | -13.89% | 1.91% | 7.14% | 2.14% | -7.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 101.48% | -8,630.32% | -8,630.32% | -8,793.30% | -8,642.66% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -136.89% | 105.19% | 1,083.51% | 659.86% | 224.93% |
| Cash from Investing | 76.61% | -757.58% | -499.01% | -489.01% | -207.44% |
| Total Debt Issued | -76.64% | -11.50% | 317.98% | 410.88% | 472.94% |
| Total Debt Repaid | 67.00% | 45.63% | -251.74% | -325.27% | -352.46% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.08% | -0.06% | -0.04% | -0.02% | 0.01% |
| Other Financing Activities | 156.38% | 145.03% | -- | -158.10% | -60.03% |
| Cash from Financing | -116.80% | 778.10% | 3,160.49% | 1,555.55% | 1,404.23% |
| Foreign Exchange rate Adjustments | 138.02% | 23.22% | 65.33% | -42.05% | -92.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -133.98% | 141.04% | -108.78% | -22.01% | 196.20% |